Skip to main content

GH Research PLC

GHRS
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001855129

No open-market purchases or sales by GH Research PLC insiders were filed in the last 90 days; 63 institutions reported holding it in 13F filings for Q2 2026, worth $1.38B in total; no superinvestor holds it.

Q3 2021 vs. Q2 2021

How the institutions holding GH Research PLC changed between Q2 2021 and Q3 2021.

All holders in Q3 2021All holders in Q2 2021

13F holders of GHRS: Q2 2021 compared with Q3 2021
MeasureQ2 2021Q3 2021Change
Holders3430−4
Shares27.6M28.5M+917.8K (+3.3%)
Value$593.7M$625.2M+$31.5M (+5.3%)

New holders (7)

Institutions that held GH Research PLC at the end of Q3 2021 but not at the end of Q2 2021.

Institutions new to GHRS in Q3 2021
InstitutionSharesValue% of portfolio
Ghost Tree Capital, LLC400,000$8.82M2.91%
Geode Capital Management, LLC27,198$599.0K0.00%
Penserra Capital Management LLC25,366$559.0K0.01%
Schonfeld Strategic Advisors LLC17,223$380.0K0.00%
AdvisorShares Investments LLC3,768$83.0K0.01%
Global Retirement Partners, LLC220$5.00K0.00%
Bank of America Corp22$00.00%

Sold out (11)

Institutions that held GH Research PLC at the end of Q2 2021 and filed for Q3 2021 without it.

Institutions that sold out of GHRS in Q3 2021
InstitutionShares, Q2 2021Value, Q2 2021
Monashee Investment Management LLC165,000$3.58M
Alyeska Investment Group, L.P.100,000$2.17M
Maven Securities LTD100,000$2.17M
Millennium Management LLC45,866$997.0K
Polar Asset Management Partners Inc.19,624$426.0K
Squarepoint Ops LLC18,000$391.0K
Qube Research & Technologies Ltd17,525$381.0K
Capstone Investment Advisors, LLC10,000$217.0K
BlackRock Inc.1,000$21.0K
Tower Research Capital LLC (TRC)837$18.0K
UBS Group AG335$7.00K